Clover Health Investments, Corp. /De filed 4 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-09-25. Between them they name 2 people. Each change below is quoted from the filing and linked to it.
Every change, newest first
Reported
On September 22, 2026, the Board of Directors (the "Board") of Clover Health Investments, Corp. ("Clover" or the "Company") appointed Senator Robert G. Torricelli to serve as a Class I director of the Board and Dr. Brian J. Miller, M.D., M.B.A., M.P.H. to serve as a Class III director of the Board.
Reported
On September 22, 2026, the Board of Directors (the "Board") of Clover Health Investments, Corp. ("Clover" or the "Company") appointed Senator Robert G. Torricelli to serve as a Class I director of the Board and Dr. Brian J. Miller, M.D., M.B.A., M.P.H. to serve as a Class III director of the Board.
Departing: Brady Priest, Chief Executive Officer, effective 2026-07-03
On June 15, 2026, Brady Priest notified Clover Health Investments, Corp. (the "Company") of his decision to step down from his position as Chief Executive Officer of Clover Care Services, the Company's home-care business, effective as of July 3, 2026.
Departing: Peter Kuipers, Chief Financial Officer
As part of this transition, effective immediately, Mr. Peter Kuipers has stepped down from his role as the Chief Financial Officer of the Company, including as principal financial officer and principal accounting officer, and the Board appointed Mr. Clay Thornton as the Interim Chief Financial Officer of the Company.
Find people with the same kind of experience as the Chief Executive Officer at Clover Health Investments, Corp. /De, with the record behind each one.
Find candidates like Chief Executive Officer at Clover Health Investments, Corp. /DeNew leaders review vendors and budgets in their first months. Get an alert the next time Clover Health Investments, Corp. /De is in the news or changes leadership.
Get an alert when Clover Health Investments, Corp. /De changes leadershipTools for this story
Each opens in a new tab, filled in for Clover Health Investments, Corp. /De. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.